OR WAIT null SECS
August 20, 2021
Bristol Myers Squibb has exercised the option to in-license an immune-modulating drug candidate developed by Exscientia.
3P Innovation has won a Princess Royal Training Award for its Graduate Development Programme (GDP).
UK's ABPI responds to the latest revisions being made to NICE methods for assessment of drugs and devices.
August 10, 2021
The agency is endorsing recommendations for global track-and-trace systems developed by the International Coalition of Medicines Regulatory Authorities.
August 09, 2021
The agency’s Pharmacovigilance Risk Assessment Committee recommended updating the product information for Janssen’s COVID-19 vaccine to list immune thrombocytopenia as an adverse reaction.
EMA’s Pharmacovigilance Risk Assessment Committee has requested more data for its evaluation of reports of Guillain-Barré syndrome after vaccination.
August 05, 2021
BMG Pharma's clinical trial has demonstrated positive results in the efficacy of BMG0705 Nasal Spray and BMG0703A Mouth Rinse as treatments for asymptomatic COVID-19 patients.
Evonik has acquired the German biotech company JeNaCell, expanding its biomaterials portfolio.
Nanoform and Boehringer Ingelheim have executed a master services agreement in relation to pre-clinical development projects.
EC has confirmed that the entry into application of the Clinical Trials Regulation and, as such, the go-live date for the Clinical Trials Information System (CTIS) will be Jan. 31, 2022.